{{Rsnum
|rsid=3764221
|Gene=CYP19A1
|Chromosome=15
|position=51296650
|Orientation=minus
|GMAF=0.1644
|Gene_s=CYP19A1,LOC100996299
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 92.0 | 8.0 | 0.0
| HCB | 70.4 | 28.1 | 1.5
| JPT | 61.6 | 30.4 | 8.0
| YRI | 43.4 | 42.1 | 14.5
| ASW | 40.4 | 52.6 | 7.0
| CHB | 70.4 | 28.1 | 1.5
| CHD | 75.2 | 22.0 | 2.8
| GIH | 69.0 | 26.0 | 5.0
| LWK | 32.1 | 45.0 | 22.9
| MEX | 82.5 | 17.5 | 0.0
| MKK | 40.6 | 46.5 | 12.9
| TSI | 97.0 | 3.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20688833
|Title=Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs
}}

{{PMID Auto
|PMID=24242679
|Title=Association of a Genetic Variant of CYP19A1 with Multicentric Development of Lung Adenocarcinomas
}}
{{on chip | Illumina Human 1M}}